SignificantEconomyAxios·Axios

How AI is supercharging drug development

A proprietary survey of 80 biopharma leaders and insiders indicates artificial intelligence is compressing drug developers' preclinical costs and timelines by as much as 70%. This trend is fueling demand for cutting-edge software and computational tools to accelerate early-stage research and generate more experimental treatments.

Impact Score

5/10

Monday, July 20, 2026 at 05:30 AM EDT

Read original source →

More Signals

And this was the US under Biden:EconomyJul 30 GOP gubernatorial candidate fighting to flip blue state unveils healthcare plan to lower costs, expand accessEconomyJul 30 President Trump’s Working Families Tax Cuts are delivering for Wisconsin families. Thanks to @POTUS and our friends like @RepBryanSteil in Congress, Wisconsin is seeing: $6,400 wage increases per family 125K jobs saved No tax on Social Security for a million Wisconsin seniorsEconomyJul 30 This is what happened under Biden. Thank goodness President Trump was elected so none of this would ever happen under his watch.EconomyJul 30 A Lose-Lose for Food StampsEconomyJul 30 Burnham told Trump UK will be ‘pragmatic’ about North Sea oil and gasEconomyJul 30

See the live signal feed at demegoria.com →